Top

Published in:

01-05-2011

The role of iron in the immune response to bacterial infection

Author: Bobby J. Cherayil

Published in: Immunologic Research | Issue 1/2011

Abstract

My laboratory has been interested for some time in the influence of iron, a nutrient that is essential for both microbial pathogens and their mammalian hosts, on the course of infectious disease. Our studies indicate that alterations in the expression of host molecules that sequester or transport iron can have direct effects on pathogen growth and can also have an impact on the ability to mount normal immune responses. We have elucidated the mechanistic basis for some of these observations, and have started to apply our findings in strategies to control abnormalities of inflammation and iron metabolism. I will review here what we have learned about the interactions between iron and immunity and discuss the implications of the information that we have acquired.

Beard JL. Iron biology in immune function, muscle metabolism and neuronal functioning. J Nutr. 2001;131:568S–80S.PubMed

Andrews NC. Forging a field: the golden age of iron biology. Blood. 2008;112:219–30.PubMedCrossRef

Hentze MW, Muckenthaler MU, Galy B, et al. Two to tango: regulation of mammalian iron metabolism. Cell. 2010;142:24–38.PubMedCrossRef

Biggs TE, Baker ST, Botham MS, et al. Nramp1 modulates iron homeostasis in vivo and in vitro: evidence for a role in cellular iron release involving de-acidification of intracellular vesicles. Eur J Immunol. 2001;31:2060–70.PubMedCrossRef

Soe-Lin S, Sheftel AD, Wasyluk B, et al. Nramp1 equips macrophages for efficient iron recycling. Exp Hematol. 2008;36:929–37.PubMedCrossRef

Soe-Lin S, Apte SS, Andriopoulos B Jr, et al. Nramp1 promotes efficient macrophage recycling of iron following erythrophagocytosis in vivo. Proc Natl Acad Sci USA. 2009;106:5960–5.PubMedCrossRef

Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399–408.PubMedCrossRef

Goswami T, Andrews NC. Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalin iron sensing. J Biol Chem. 2006;281:28494–8.PubMedCrossRef

Schmidt PJ, Toran PT, Giannetti AM, et al. The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression. Cell Metab. 2008;7:205–14.PubMedCrossRef

10.

Gao J, Chen J, Kramer M, et al. Interaction of the hereditary hemochromatosis protein, HFE, with transferrin receptor 2 is required for transferrin-induced hepcidin expression. Cell Metab. 2009;9:217–27.PubMedCrossRef

11.

Andriopoulos B, Corradini E, Xia Y, et al. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet. 2009;41:482–7.PubMedCrossRef

12.

Meynard D, Kautz L, Darnaud V, et al. Lack of BMP6 induces massive iron overload. Nat Genet. 2009;41:478–81.PubMedCrossRef

13.

Ganz T, Nemeth E. Hepcidin and disorders of iron metabolism. Annu Rev Med. 2011;62:13.1–4. (epub ahead of print).CrossRef

14.

Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306:2090–3.PubMedCrossRef

15.

De Domenico I, Ward DM, Langelier C, et al. The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol Biol Cell. 2007;18:2569–78.PubMedCrossRef

16.

De Domenico I, Lo E, Ward DM, et al. Hepcidin-induced internalization of ferroportin requires binding and cooperative interaction with Jak2. Proc Natl Acad Sci USA. 2009;106:3800–5.PubMedCrossRef

17.

Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113:1271–6.PubMed

18.

Lee P, Peng H, Gelbart T, Beutler E. The IL-6 and LPS-induced transcription of hepcidin in Hfe- TfR2- and β2-microglobulin-deficient mice. Proc Natl Acad Sci USA. 2004;101:9263–5.PubMedCrossRef

19.

Lee P, Peng H, Gelbart T, et al. Regulation of hepcidin transcription by IL-1 and IL-6. Proc Natl Acad Sci USA. 2005;102:1906–10.PubMedCrossRef

20.

Muckenthaler MU, Galy B, Hentze MW. Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network. Annu Rev Nutr. 2008;28:197–213.PubMedCrossRef

21.

Wang L, Cherayil BJ. Ironing out the wrinkles in host defense: interactions between iron homeostasis and innate immunity. J Innate Immun. 2009;1:455–64.PubMedCrossRef

22.

Forbes JR, Gros P. Divalent metal transport by NRAMP proteins at the interface of host-pathogen interactions. Trends Microbiol. 2001;9:397–403.PubMedCrossRef

23.

Cellier MF, Courville P, Campion C. Nramp1 phagocyte intracellular metal withdrawal defense. Microbes Infect. 2007;9:1662–70.PubMedCrossRef

24.

Moller M, Hoal EG. Current findings, challenges and novel approaches to human genetic susceptibility to tuberculosis. Tuberculosis (Edinb). 2010;90:71–83.CrossRef

25.

Chlosta S, Fishman DS, Harrington L, et al. The iron efflux protein ferroportin regulates the intracellular growth of Salmonella enterica. Infect Immun. 2006;74:3065–7.PubMedCrossRef

26.

Olakanmi O, Schlesinger LS, Britigan BE. Hereditary hemochromatosis results in decreased iron acquisition and growth by Mycobacterium tuberculosis within human macrophages. J Leukoc Biol. 2007;81:195–204.PubMedCrossRef

27.

Nairz M, Theurl I, Ludwiczek S, et al. The co-ordinated regulation of iron homeostasis in murine macrophages limits the availability of iron for intracellular Salmonella typhimurium. Cell Microbiol. 2007;9:2126–40.PubMedCrossRef

28.

Paradkar PN, De Domenico I, Durchfort N, et al. Iron depletion limits intracellular bacterial growth in macrophages. Blood. 2008;112:866–74.PubMedCrossRef

29.

Nairz M, Fritsche G, Brunner P, et al. Interferon γ limits the availability of iron for intra-macrophage Salmonella typhimurium. Eur J Immunol. 2008;38:1923–36.PubMedCrossRef

30.

Peyssonaux C, Zinkernagel AS, Datta V, et al. TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood. 2006;107:3727–32.CrossRef

31.

Nguyen NB, Callaghan KD, Ghio AJ, et al. Hepcidin expression and iron transport in alveolar macrophages. Am J Physiol Lung Cell Mol Physiol. 2006;291:L417–25.PubMedCrossRef

32.

Theurl I, Theurl M, Seifert M, et al. Autocrine formation of hepcidin induces iron retention in human monocytes. Blood. 2008;111:2392–9.PubMedCrossRef

33.

Schaible UE, Kaufmann SH. Iron and microbial infection. Nat Rev Microbiol. 2004;2:946–53.PubMedCrossRef

34.

Doherty CP. Host-pathogen interactions: the role of iron. J Nutr. 2007;137:1341–4.PubMed

35.

Pietrangelo A. Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology. 2010;139:393–408.PubMedCrossRef

36.

Zhou XY, Tomatsu S, Fleming RE, et al. Hfe gene knock-out produces a mouse model of hereditary hemochromatosis. Proc Natl Acad Sci USA. 1998;95:2492–7.PubMedCrossRef

37.

Wang L, Johnson EE, Shi HN, et al. Attenuated inflammatory responses in hemochromatosis reveal a role for iron in the regulation of macrophage cytokine translation. J Immunol. 2008;181:2723–31.PubMed

38.

Gomes-Pereira S, Rodrigues PN, Appelberg R, et al. Increased susceptibility to Mycobacterium avium in hemochromatosis protein Hfe-deficient mice. Infect Immun. 2008;76:4713–9.PubMedCrossRef

39.

Johnson EE, Sandgren A, Cherayil BJ, et al. Role of ferroportin in macrophage-mediated immunity. Infect Immun. 2010;78:5099–106.PubMedCrossRef

40.

Wang L, Harrington L, Trebicka E, et al. Selective modulation of TLR4-activated inflammatory responses by altered iron homeostasis in mice. J Clin Invest. 2009;119:3322–8.PubMed

41.

Sheedy FJ, O’Neill LA. The Troll in Toll: Mal and TRAM as bridges for TLR2 and TLR4 signaling. J Leukoc Biol. 2007;82:196–203.PubMedCrossRef

42.

Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010;11:373–84.PubMedCrossRef

43.

Kagan JC, Su T, Horng T, et al. TRAM couples endocytosis of TLR4 to the induction of interferon-beta. Nat Immunol. 2008;9:361–8.PubMedCrossRef

44.

Nairz M, Theurl I, Schroll A, et al. Absence of functional Hfe protects mice from invasive Salmonella enterica serovar Typhimurium infection via induction of lipocalin-2. Blood. 2009;114:3642–51.PubMedCrossRef

45.

Levy JE, Montross LK, Cohen DE, et al. The C282Y mutation causing hereditary hemochromatosis does not produce a null allele. Blood. 1999;94:9–11.PubMed

46.

Bahram S, Gilfillan S, Kuhn LC, et al. Experimental hemochromatosis due to MHC class I HFE deficiency: immune status and iron metabolism. Proc Natl Acad Sci USA. 1999;96:13312–7.PubMedCrossRef

47.

De Domenico I, Zhang TY, Branch LW, et al. Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice. J Clin Invest. 2010;120:2395–405.PubMedCrossRef

48.

Bullen JJ, Spalding PB, Ward CG, et al. Hemochromatosis, iron and septicemia caused by Vibrio vulnificus. Arch Intern Med. 1991;151:1606–9.PubMedCrossRef

49.

Bergmann TK, Vinding K, Hey H. Multiple hepatic abscesses due to Yersinia enterocolitica infection secondary to primary hemochromatosis. Scand J Gastroenterol. 2001;36:891–5.PubMedCrossRef

50.

Wright AC, Simpson LM, Oliver JD. Role of iron in the pathogenesis of Vibrio vulnificus infections. Infect Immun. 1981;34:503–7.PubMed

51.

Gordeuk VR, Ballou S, Lozanski G, et al. Decreased concentrations of TNFα in supernatants of monocytes from homozygotes for hereditary hemochromatosis. Blood. 1992;79:1855–60.PubMed

52.

Gordeuk VR, Caleffi A, Corradini E, et al. Iron overload in Africans and African-Americans and a common mutation in the SLC40A1 (ferroportin 1) gene. Blood Cells Mol Dis. 2003;31:299–304.PubMedCrossRef

53.

Beutler E, Barton JC, Felitti VJ, et al. Ferroportin 1 (SLC40A1) variant associated with iron overload in African-Americans. Blood Cells Mol Dis. 2003;31:305–9.PubMedCrossRef

54.

McNamara L, Gordeuk VR, MacPhail AP. Ferroportin (Q248H) mutations in African families with dietary iron overload. J Gastroenterol Hepatol. 2005;20:1855–8.PubMedCrossRef

55.

Boelaert JR, Vandecasteele SJ, Appelberg R, et al. The effect of the host’s iron status on tuberculosis. J Infect Dis. 2007;195:1745–53.PubMedCrossRef

56.

Gomolion F, Gisbert JP. Anemia and inflammatory bowel diseases. World J Gastroenterol. 2009;15:4659–65.CrossRef

57.

Stein J, Hartmann F, Dignass AU. Diagnosis and management of iron deficiency anemia in patients with IBD. Nat Rev Gastroenterol Hepatol. 2010;7:599–610.PubMedCrossRef

58.

Ganz T, Nemeth E. Iron sequestration and anemia of inflammation. Semin Hematol. 2009;46:387–93.PubMedCrossRef

59.

Wessling-Resnick M. Iron homeostasis and the inflammatory response. Annu Rev Nutr. 2010;30:105–22.PubMedCrossRef

60.

Semrin G, Fishman DS, Bousvaros A, et al. Impaired intestinal iron absorption in Crohn’s disease correlates with disease activity and markers of inflammation. Inflamm Bowel Dis. 2006;12:1101–6.PubMedCrossRef

61.

Cherayil BJ. Cross-talk between iron homeostasis and intestinal inflammation. Gut Microbes. 2010;1:65–9.PubMedCrossRef

62.

Babitt JL, Huang FW, Xia Y, et al. Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J Clin Invest. 2007;117:1933–9.PubMedCrossRef

63.

Yu PB, Hong CC, Sachidanandan C, et al. Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol. 2008;4:33–41.PubMedCrossRef

64.

Berg DJ, Zhang J, Weinstock JV, et al. Rapid development of colitis in NSAID-treated IL-10-deficient mice. Gastroenterology. 2002;123:1527–42.PubMedCrossRef

65.

Legrand D, Mazurier J. A critical review of the roles of host lactoferrin in immunity. Biometals. 2010;23:365–76.PubMedCrossRef

66.

Ward PP, Mendoza-Meneses M, Park PW, et al. Stimulus-dependent impairment of neutrophil oxidative burst response in lactoferrin-deficient mice. Am J Pathol. 2008;172:1019–29.PubMedCrossRef

67.

Clifton MC, Corrent C, Strong RK. Siderocalins: siderophore-binding proteins of the innate immune system. Biometals. 2009;22:557–64.PubMedCrossRef

68.

Goetz DH, Holmes MA, Borregaard N, et al. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell. 2002;10:1033–43.PubMedCrossRef

69.

Miethke M, Marahiel MA. Siderophore-based iron acquisition and pathogen contol. Microbiol Mol Biol Rev. 2007;71:413–51.PubMedCrossRef

70.

Flo TH, Smith KD, Sato S, et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature. 2004;432:917–21.PubMedCrossRef

71.

Berger T, Togawa A, Duncan GS, et al. Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc Natl Acad Sci USA. 2006;103:1834–9.PubMedCrossRef

72.

Chan YR, Liu JS, Pociask DA, et al. Lipocalin 2 is required for pulmonary host defense against Klebsiella infection. J Immunol. 2009;182:4947–56.PubMedCrossRef

73.

Fischbach MA, Lin H, Liu DR, et al. How pathogenic bacteria evade mammalian sabotage in the battle for iron. Nat Chem Biol. 2006;2:132–8.PubMedCrossRef

74.

Fischbach MA, Lin H, Zhou L, et al. The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2. Proc Natl Acad Sci USA. 2006;103:16502–7.PubMedCrossRef

75.

Raffatellu M, George MD, Akiyama Y, et al. Lipocalin 2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe. 2009;5:476–86.PubMedCrossRef

76.

Holmes MA, Paulsene W, Jide X, et al. Siderocalin (Lcn2) also binds carboxymycobactins, potentially defending against mycobacterial infections through iron sequestration. Structure. 2005;13:29–41.PubMedCrossRef

77.

Saiga H, Nishimura J, Kuwata H, et al. Lipocalin 2-dependent inhibition of mycobacterial growth in alveolar epithelium. J Immunol. 2008;181:8521–7.PubMed

78.

Johnson EE, Srikanth CV, Sandgren A, et al. Siderocalin inhibits the intracellular replication of Mycobacterium tuberculosis in macrophages. FEMS Immunol Med Microbiol. 2010;58:138–45.PubMedCrossRef

79.

Martineau AR, Newton SM, Wilkinson KA, et al. Neutrophil-mediated innate immune resistance to mycbacteria. J Clin Invest. 2007;117:1988–94.PubMedCrossRef

80.

Landro L, Damas JK, Flo TH, et al. Decreased serum lipocalin 2 levels in human immunodeficiency virus-infected patients: increase during highly active anti-retroviral therapy. Clin Exp Immunol. 2008;152:57–63.PubMedCrossRef

81.

Devireddy LR, Hart DO, Goetz DH, et al. A mammalian siderophore synthesized by an enzyme with a bacterial homolog involved in enterobactin production. Cell. 2010;141:1006–17.PubMedCrossRef

82.

Bao G, Clifton M, Hoette TM, et al. Iron traffics in circulation bound to a siderocalin (NGAL)-catechol complex. Nat Chem Biol. 2010;6:602–9.PubMedCrossRef

83.

Philpott C. Bioinorganic chemistry: getting a grip on iron. Nat Chem Biol. 2010;6:568–70.PubMedCrossRef

84.

Yang J, Goetz D, Li JY, et al. An iron delivery pathway mediated by lipocalin. Mol Cell. 2002;10:1045–56.PubMedCrossRef

85.

Kaplan J. Mechanisms of cellular iron acquisition: another iron in the fire. Cell. 2002;111:603–6.PubMedCrossRef

86.

Devireddy LR, Gazin C, Zhu X, et al. A cell surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell. 2005;123:1293–305.PubMedCrossRef

87.

Richardson DR. 24p3 and its receptor: dawn of a new iron age? Cell. 2005;123:1175–7.PubMedCrossRef

88.

Breuer W, Shvartsman M. Cabantchik ZI: Intracellular labile iron. Int J Biochem Cell Biol. 2008;40:350–4.PubMedCrossRef

89.

Kell DB. Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular, other progressive inflammatory, degenerative diseases. BMC Med Genomics. 2009;2:2.PubMedCrossRef

90.

Kell DB. Towards a unifying systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples. Arch Toxicol. 2010;84:825–89.PubMedCrossRef

91.

Baker M, Wilson D, Sabeti PC, et al. Host genetic factors involved in iron regulation may influence susceptibility to Mycobacterium tuberculosis: a pilot study. Abstract presented at the Fourth Annual New England TB Symposium, July 2010.

Title: The role of iron in the immune response to bacterial infection
Author: Bobby J. Cherayil
Publication date: 01-05-2011
Publisher: Humana Press Inc
Published in: Immunologic Research / Issue 1/2011
Print ISSN: 0257-277X
Electronic ISSN: 1559-0755
DOI: https://doi.org/10.1007/s12026-010-8199-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The role of iron in the immune response to bacterial infection

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2011

Impaired pulmonary immunity post-bone marrow transplant

Transcriptional regulation by STAT6

Biology and function of neuroimmune semaphorins 4A and 4D

Immunological alterations mediated by adenosine during host-microbial interactions

Tonsillar CD4+FOXP3+ T-regulatory cell dynamics in primary EBV infection

Transcriptional control mechanisms associated with the nucleotide receptor P2X7, a critical regulator of immunologic, osteogenic, and neurologic functions